Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2026-09-21 18:30:10 ET · period of report 2025-08-06 · accession 0001193125-26-396935 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 18:30 | 2025-08-06 | CRSP | Behbahani Ali | Dir | J - Other | $0.00 | +60 | 316 | +23% | $0 | |
| I | 2026-09-21 18:30 | 2025-08-06 | CRSP | Behbahani Ali | Dir | J - Other | $0.00 | +15 | 29 | +107% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-08-06 | J | A | 60 | $0.00 | 316 | D | — | — | (F1) NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025. |
| 2 | Common | Common Shares | 2025-08-06 | J | A | 15 | $0.00 | 29 | I See Note 3 | — | — | (F2) The Ali Behbahani Revocable Trust Dated June 26, 2015 (the "Behbahani Trust") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025. (F3) The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest. |